
Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Pharming Group
Market Cap: €704.5m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€1.02
7D
2.2%
1Y
-11.7%
Vivoryon Therapeutics
Market Cap: €33.3m
Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.
VVY
€1.15
7D
2.2%
1Y
-20.7%